Serna-Blasco R, Mediavilla-Medel P, Medina K, Sala MA, et al. Comprehensive molecular profiling of advanced NSCLC using NGS: Prevalence of druggable mutations and clinical trial opportunities in the ATLAS study. Lung Cancer 2025;204:108550.
PMID: 40300279